Partanen T A, Vikatmaa P, Tukiainen E, Lepäntalo M, Vuola J
Department of Surgery, Division of Plastic Surgery, Töölö Hospital, Helsinki University Central Hospital, Finland.
Eur J Vasc Endovasc Surg. 2009 Jun;37(6):704-11. doi: 10.1016/j.ejvs.2009.01.016. Epub 2009 Mar 26.
To retrospectively analyse injection drug users (IDUs) with complications after intra- or extra-vasal administration of dissolved tablets.
A retrospective study.
The hospital discharge registers were used to identify the patients admitted in different clinics in Helsinki University Central Hospital during 2000-2005. The patient demographics and social background were clarified. The type of the crushed drugs, the injection route and the timing of administration were registered. Medical interventions, examinations and surgical procedures were recorded.
Between January 2000 and December 2005, 24 patients had been treated on 30 occasions for manifestations caused by injecting crushed tablets. The main types of manifestations were acute limb ischaemia (16 patients) and infection (eight patients), and eight cases led to distal or proximal amputations. Men (19 of 24) were affected more frequently than were women (5 of 24). Their ages ranged between 20 and 39 years (mean: 26 years). All the patients had a previous history of intravenous drug abuse, and they lived in Greater Helsinki region. The incidence of seropositivity for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) was 33% (n=8), 88% (n=21) and 4% (n=1), respectively. The time between injection and presentation to the Emergency Department varied between 3h and 10 days (mean: 62 h). Buprenorphine was the most commonly used drug in 10 of the 24 patients, and benzodiazepine derivatives were also used in 11 of the 24 patients.
Intra- or extra-vasal administration of dissolved tablets leads to serious consequences, including limb amputations. Vascular and soft-tissue imaging may be helpful in the diagnosis. Prompt drainage of any abscess and fasciotomies for compartment syndrome treatment are essential. Controversy exists over the best medical therapy.
回顾性分析溶解片血管内或血管外给药后出现并发症的注射吸毒者。
一项回顾性研究。
利用医院出院登记册确定2000年至2005年期间在赫尔辛基大学中心医院不同科室住院的患者。明确患者的人口统计学特征和社会背景。记录碾碎药物的类型、注射途径和给药时间。记录医疗干预、检查和外科手术情况。
2000年1月至2005年12月期间,24例患者因注射碾碎片引起的症状接受了30次治疗。主要症状类型为急性肢体缺血(16例患者)和感染(8例患者),8例导致远端或近端截肢。男性(24例中的19例)比女性(24例中的5例)更易受影响。他们的年龄在20至39岁之间(平均:26岁)。所有患者既往均有静脉药物滥用史,且居住在大赫尔辛基地区。乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)和人类免疫缺陷病毒(HIV)血清阳性率分别为33%(n = 8)、88%(n = 21)和4%(n = 1)。从注射到就诊于急诊科的时间在3小时至10天之间(平均:62小时)。丁丙诺啡是24例患者中10例最常用的药物,苯二氮䓬类衍生物在24例患者中11例也有使用。
溶解片血管内或血管外给药会导致严重后果,包括肢体截肢。血管和软组织成像可能有助于诊断。及时引流任何脓肿以及进行筋膜切开术以治疗骨筋膜室综合征至关重要。关于最佳药物治疗存在争议。